Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1261

1.

Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention.

Ozer N, Tangurek B, Firat F, Ozer S, Tartan Z, Ozturk R, Ozay B, Ciloglu F, Yilmaz H, Cam N.

Heart Vessels. 2008 Mar;23(2):75-82. doi: 10.1007/s00380-007-1020-y. Epub 2008 Apr 4.

PMID:
18389330
[PubMed - indexed for MEDLINE]
2.

Impact of direct sirolimus-eluting stent implantation on the early systemic inflammatory response compared with complementary stent implantation.

Li JJ, Zhang YP, Wang C, Gao LJ, Qin XW, Xu B, Chen JL, Yang YJ, Gao RL.

Coron Artery Dis. 2009 Jan;20(1):65-70. doi: 10.1097/MCA.0b013e32830d27bd.

PMID:
19018239
[PubMed - indexed for MEDLINE]
3.

Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents.

Kang WC, Ahn TH, Moon CI, Han SH, Shin EK, Kim JS, Ko YG, Choi D, Jang Y, Kim BK, Oh SJ, Jeon DW, Yang JY.

Heart. 2009 Jun;95(12):970-5. doi: 10.1136/hrt.2008.153114. Epub 2008 Sep 4.

PMID:
18772180
[PubMed - indexed for MEDLINE]
4.

Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels.

Kim JY, Ko YG, Shim CY, Park S, Hwang KC, Choi D, Jang Y, Chung N, Shim WH, Cho SY.

Am J Cardiol. 2005 Nov 15;96(10):1384-8. Epub 2005 Sep 27.

PMID:
16275183
[PubMed - indexed for MEDLINE]
5.

A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.

Rathore S, Kinoshita Y, Terashima M, Katoh O, Matsuo H, Tanaka N, Kimura M, Tsuchikane E, Nasu K, Ehara M, Asakura K, Asakura Y, Suzuki T.

EuroIntervention. 2010 Feb;5(7):841-6.

PMID:
20142201
[PubMed - indexed for MEDLINE]
6.

Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation.

Li JJ, Yan HB, Xiang XP, Qin XW, Zhang CY.

Cardiovasc Drugs Ther. 2009 Apr;23(2):137-43. doi: 10.1007/s10557-008-6149-0. Epub 2008 Nov 19.

PMID:
19016317
[PubMed - indexed for MEDLINE]
7.

Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study.

Kubo T, Imanishi T, Kitabata H, Kuroi A, Ueno S, Yamano T, Tanimoto T, Matsuo Y, Masho T, Takarada S, Tanaka A, Nakamura N, Mizukoshi M, Tomobuchi Y, Akasaka T.

JACC Cardiovasc Imaging. 2008 Jul;1(4):475-84. doi: 10.1016/j.jcmg.2008.03.012.

PMID:
19356470
[PubMed - indexed for MEDLINE]
Free Article
8.

Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis.

Ishii H, Toriyama T, Aoyama T, Takahashi H, Amano T, Hayashi M, Tanaka M, Kawamura Y, Yasuda Y, Yuzawa Y, Maruyama S, Matsuo S, Matsubara T, Murohara T.

Circ Cardiovasc Interv. 2009 Dec;2(6):513-8. doi: 10.1161/CIRCINTERVENTIONS.109.889915. Epub 2009 Oct 13.

PMID:
20031768
[PubMed - indexed for MEDLINE]
Free Article
9.

Comparison of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents.

Rebeiz AG, Zoghbi E, Harb R, Youhanna S, Skouri HN, Dimassi A, Abou-Nader G, Nasrallah A, Sawaya J, Gharzuddine W, Alam S.

J Interv Cardiol. 2009 Apr;22(2):169-74. doi: 10.1111/j.1540-8183.2009.00429.x. Epub 2009 Feb 24.

PMID:
19245380
[PubMed - indexed for MEDLINE]
10.

Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON).

Rozenman Y, Witzling V, Tamari I, Turkisher V, Kriviski M, Bode C, Henry P, Teiger E, Cebrian A, Stoll HP, Spaulding C.

EuroIntervention. 2009 Jun;5(2):219-23.

PMID:
19527979
[PubMed - indexed for MEDLINE]
11.

Comparison of bare metal stent with pioglitazone versus sirolimus-eluting stent for percutaneous coronary intervention in patients with Type 2 diabetes mellitus.

Nishio K, Shigemitsu M, Kodama Y, Konno N, Katagiri T, Kobayashi Y.

Cardiovasc Revasc Med. 2009 Jan-Mar;10(1):5-11. doi: 10.1016/j.carrev.2008.06.004.

PMID:
19159848
[PubMed - indexed for MEDLINE]
12.

C-Reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents.

Gaspardone A, Versaci F, Tomai F, Citone C, Proietti I, Gioffrè G, Skossyreva O.

Am J Cardiol. 2006 May 1;97(9):1311-6. Epub 2006 Mar 20.

PMID:
16635602
[PubMed - indexed for MEDLINE]
13.

Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.

Whan Lee C, Kim SH, Suh J, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.

Catheter Cardiovasc Interv. 2008 Apr 1;71(5):594-8. doi: 10.1002/ccd.21399.

PMID:
18311841
[PubMed - indexed for MEDLINE]
14.

Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.

Kozinski M, Krzewina-Kowalska A, Kubica J, Zbikowska-Gotz M, Dymek G, Piasecki R, Sukiennik A, Grzesk G, Bogdan M, Chojnicki M, Dziedziczko A, Sypniewska G.

Inflamm Res. 2005 May;54(5):187-93.

PMID:
15953990
[PubMed - indexed for MEDLINE]
15.

Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.

van Domburg RT, Daemen J, Morice MC, de Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, van Es GA, Wittebols K, Macours N, Stoll HP, Serruys PW.

EuroIntervention. 2010 Apr;5(8):962-7. doi: 10.4244/.

PMID:
20542782
[PubMed - indexed for MEDLINE]
16.

Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention study.

Atary JZ, Bergheanu SC, van der Hoeven BL, Atsma DE, Bootsma M, van der Kley F, Zeppenfeld K, Jukema JW, Schalij MJ.

EuroIntervention. 2009 Nov;5(5):565-72.

PMID:
20142177
[PubMed - indexed for MEDLINE]
17.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Review.

PMID:
19952925
[PubMed - indexed for MEDLINE]
18.

Assessment of potential relationship between wall shear stress and arterial wall response after bare metal stent and sirolimus-eluting stent implantation in patients with diabetes mellitus.

Suzuki N, Nanda H, Angiolillo DJ, Bezerra H, Sabaté M, Jiménez-Quevedo P, Alfonso F, Macaya C, Bass TA, Ilegbusi OJ, Costa MA.

Int J Cardiovasc Imaging. 2008 Apr;24(4):357-64. Epub 2007 Oct 31.

PMID:
17972162
[PubMed - indexed for MEDLINE]
19.

Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.

Slottow TL, Steinberg DH, Roy P, Javaid A, Buch AN, Okabe T, Xue Z, Smith K, Torguson R, Pichard AD, Satler LF, Suddath WO, Kent KM, Waksman R.

Cardiovasc Revasc Med. 2008 Jan-Mar;9(1):24-8. doi: 10.1016/j.carrev.2007.06.002.

PMID:
18206634
[PubMed - indexed for MEDLINE]
20.

Do drug elution components increase the risk of fracture of sirolimus-eluting stents?

Kawai T, Umeda H, Ota M, Hattori K, Ishikawa M, Okumura M, Kan S, Nakano T, Naruse H, Matsui S, Ishii J, Hishida H, Ozaki Y.

Coron Artery Dis. 2010 Aug;21(5):298-303.

PMID:
20617542
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk